Resof Total 400mg, 100mg Tablet About
Experience the latest in anti-viral excellence with Resof Total 400mg, 100mg Tablets-a laureate therapy for chronic Hepatitis C virus (HCV) infection. Featuring top-notch NS5B and NS5A inhibitor combination, these pharmaceutical grade, film-coated pink tablets provide an inestimable advantage in viral suppression. Originating from India and approved across Canada, EU, UK, USA, and Australia, Resof Total offers a personalised solution at a true bargain for patients worldwide. Marketed by Dr. Reddy's Laboratories Ltd., this prescription medicine must be used strictly under medical supervision. Storage below 30C is advised.
Comprehensive Application and Targeted Usage
Resof Total 400mg, 100mg Tablet is designed strictly for oral administration in adults dealing with chronic Hepatitis C virus (HCV) infection. This allopathic medication, assessed at not less than 98% potency per active ingredient, delivers a tailored approach for patients who require sustained anti-viral intervention. The plant-produced formulation aligns with rigorous pharmaceutical standards, making it particularly suitable for long-term, targeted therapy in HCV-infected individuals.
Domestic Market Reach and Quotation Details
Resof Total 400mg, 100mg Tablets are primarily supplied within India but are also available for export upon client quotation requests. Prospective buyers may request sample availability for product valuation prior to large orders. Payment terms are flexible, catering to minimized expenditure and optimal transaction efficiency. The main domestic market includes leading hospitals, pharmacies, and healthcare distributors, ensuring widespread availability across metropolitan and regional centers.
FAQ's of Resof Total 400mg, 100mg Tablet:
Q: How should Resof Total 400mg, 100mg Tablet be administered for optimal effectiveness?
A: Resof Total 400mg, 100mg Tablet should be taken orally, precisely as prescribed by a medical professional, to ensure optimal effectiveness in the treatment of chronic Hepatitis C infection.
Q: What are the main benefits of using Resof Total for HCV therapy?
A: The tablet offers top-notch efficacy, combining Sofosbuvir and Velpatasvir to effectively inhibit HCV replication, thus providing inestimable relief and improved treatment outcomes for patients.
Q: When can a patient expect to see the effects of this latest anti-viral agent?
A: Treatment response timelines can vary, but most patients experience a measurable decrease in viral load within weeks of initiating therapy with Resof Total under medical supervision.
Q: Where is Resof Total 400mg, 100mg Tablet approved and available for purchase?
A: Resof Total is approved for use in multiple countries, including Canada, EU, UK, USA, and Australia, and is also widely available within India through authorized suppliers and healthcare facilities.
Q: What is the process for obtaining a quotation or valuation for domestic or export orders?
A: Hospitals, pharmacies, and traders can request quotations or product valuation by contacting the supplier or manufacturer directly, after which samples and payment terms can be discussed based on order quantity.